We use cookies for a better user experience. Read our Privacy Policy

I Agree

Pericardiocentesis Procedures Market

Pericardiocentesis Procedures Market (Indication: Infections, Malignancies, Inflammatory/Rheumatology, Cardiac, and Others; and End User: Hospitals, Cardiac Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

CT-guided Catheter Drainage Method Aids in Assessment of Postoperative PE Cases

Several methods are being used for the treatment of pericardial effusion (PE) in the pericardiocentesis procedures market. As such, there is a growing awareness about echocardiography (ECHO) as one of the most valuable tools for assessing PE. M-mode ECHO is advantageous to detect even a small amount of fluid accumulated in the pericardium sac around the heart. Thus, advanced medical practices in the pericardiocentesis procedures market are boosting its revenue, which is anticipated to reach a value of ~US$ 230 Mn by the end of 2027.

Tomography and MRI (Magnetic Resonance Imaging) are also emerging as effective tools for the detection of PE. Likewise, CT (Computed Tomography) is being highly publicized as a guiding method in pericardiocentesis procedures. CT also helps in the assessment of postoperative PE. High frequency of localized effusion in postoperative cases has created a demand for CT. As such, CT-guided catheter drainage method is gaining popularity in pericardiocentesis procedures. Healthcare practitioners, especially in cardiac centers are focusing on reduced morbidity and mortality to build their credibility in the market landscape.

pericardiocentesis procedures market infographic

To know the scope of our report Get a Sample on Pericardiocentesis Procedures Market 

ECHO Machines and Other Tools Reduce Complications during Pericardiocentesis Procedures

Pericardiocentesis procedures are being performed using real-time imaging adjuncts such as transthoracic echocardiography (TTE) or fluoroscopy in order to reduce procedural complications among patients. These procedures are conducted using ECHO machines and require sterile drapes, syringes, needles and local anesthetics, among others. Hence, stakeholders in the pericardiocentesis procedures market are strategizing on increasing their production capacities to increase the availability of equipment and tools that help to overcome any hurdles that healthcare practitioners might come across.

Get a glimpse of the in-depth analysis through our Report Brochure

Cardiac indications of hemodynamic instability and cardiac arrest have led to high prevalence of emergency PE cases worldwide. This explains why the revenue of cardiac indications is projected for exponential growth in the pericardiocentesis procedures market. Other prerequisites such as alligator clip connectors and novel nasogastric tubes are being increasingly used to lower the risk of gastric perforation during surgical procedures. Growing awareness about patient positioning and monitoring are bolstering the credibility of cardiologists and surgeons in hospitals.

Ultrasound-guided Pericardiocentesis Makes Surgeons More Proficient in Treatment of Cardiac Tamponade

Currently, the highest number of pericardiocentesis procedures are anticipated to be carried out in North America and Europe by the end of 2020. However, expensive simulations models are posing as a hurdle for learners and practitioners in the market for pericardiocentesis procedures. This explains why the pericardiocentesis procedures market is projected to expand at a modest CAGR of ~4% during the forecast period. Hence, companies are increasing their research in the low-cost and reusable ultrasound pericardiocentesis simulation model, which is transforming the lives of emergency medicine residents and emergency medicine-bound students.

Cardiac tamponade is a time sensitive and life-threatening condition that demands immediate intervention. Though incidence rate of cardiac tamponade among the U.S. population is much less, it is crucial for cardiologists, surgeons, and radiologists to be proficient during the life-saving procedure. Hence, ultrasound-guided pericardiocentesis is generating lucrative opportunities for growth in the pericardiocentesis procedures market.

Ongoing Research and Education Support High-quality and Innovative Therapeutic Treatments

Companies in the pericardiocentesis procedures market are increasing their efforts in research and education to offer high quality and innovative therapies to patients. They are adopting the multi-disciplinary approach for comprehensive care of patients with pericardial diseases. With the help of state-of-the-art diagnostic testing healthcare providers in the pericardiocentesis procedures market are improving their clinical numbers. In order to improve patient quality of life, cardiologists and clinicians are informing the patients about the possible risks and benefits of pericardiocentesis procedures. In order to further enhance healthcare outcomes, the use of ultrasound or fluoroscopy is highly recommended for lowering the risks of complications during surgical procedures.

ECHO machines are being increasingly used for the diagnosis of PE, and also to determine the severity of the effusion. Other treatment methods such as subxiphoid tube pericardiostomy and anterior thoracotomy with pericardiopleural window opening are generating revenue streams for healthcare providers. Pericardiocentesis procedures are being preferred by individuals after thorough analysis of the patient’s medical history.

pericardiocentesis procedures market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

Apart from cardiac applications, the market value share of malignancies is projected to take a leap from ~35% in 2018 to an estimated 38.5% by 2027. Since PE, cardiac tamponade, and other pericardial diseases are some of the life-threatening diseases and demand immediate intervention, there is a surging need for experienced cardiologists and surgeons that help to improve patient outcomes.

Low-cost ultrasound-guided pericardiocentesis is one of the key takeaways that is being highly publicized for making practitioners more proficient in surgical procedures. However, several cardiologists and surgeons lack thorough knowledge about uncorrected coagulopathy and about the anatomy of the chest, thus resulting in complications in patients. Since withdrawal of even small amount of fluid significantly extends the lifetime expectancy of patients by several months and years, companies should increase awareness about patient positioning and monitoring to reduce complications during procedures.

Pericardiocentesis Procedures Market: Overview

  • The global pericardiocentesis procedures market was valued at ~US$ 161 Mn in 2018 and is projected to expand at a high CAGR from 2019 to 2027. Globally, around 10,047 pericardiocentesis surgeries were performed in 2018. High prevalence and increase in incidence rate of cancer, cardiovascular diseases, and infectious diseases across the globe and rapidly increasing geriatric population are anticipated to fuel the growth of the global pericardiocentesis procedures market.
  • Pericardiocentesis is a minimally invasive cardiac surgery performed to aspire the excess pericardial fluid accumulated in pericardium sac due to various medical conditions. Pericardiocentesis is one of the most promising surgeries performed for the early management of large, symptomatic pericardial effusion and cardiac tamponade.
  • The pericardial effusion is a result of cardiac tamponade that leads to life threatening compression of heart due to increased pericardial fluid
  • A number of medical conditions could lead to the development of cardiac tamponade. These are breast cancer, lung cancer, lymphoma, bacterial & viral infections, tuberculosis, trauma & damage near heart, post radiation therapy & chemotherapy complications, end-stage renal diseases, and cardiovascular disorders.
  • The global pericardiocentesis procedures market is expected to be driven by high prevalence and increase in incidence rate of malignancy cancer cases and rapidly increasing geriatric population across the globe. According to the World Cancer Research Fund Organization, 2,088,849 cases of breast cancer were reported globally in 2018. The organization estimated that the number of breast cancer cases would reach 5.5 million across the world by the end of 2030.
  • Gradual shift from open heart surgery to minimally invasive surgeries is one of the major trends in cardiac surgeries across the globe. In countries such as India, minimally invasive surgeries are preferred by cardiac surgeons. It is gaining momentum in various parts of the country driven by an increase in deployment of advanced medical technologies at tertiary care centers. Increase in minimally invasive cardiac surgeries at healthcare facilities is likely to transform the delivery of care and provide positive outcomes.

Pericardiocentesis Procedures Market: Segmentation

  • The global pericardiocentesis procedures market has been segmented based on indication, end user, and region
  • In terms of indication, the global pericardiocentesis procedures market has been categorized into infections, malignancies, cardiac, inflammatory/rheumatology, and others. The malignancies segment is projected to lead the global pericardiocentesis procedures market during the forecast period. The segment has been classified into lung cancer, breast cancer, lymphoma, and others.
  • Based on end user, the global pericardiocentesis procedures market has been divided into hospitals, cardiac centers, and others. The hospitals segment dominated the global pericardiocentesis procedures market in 2018 and the trend is expected to continue from 2019 to 2027.

Pericardiocentesis Procedures Market: Regional Segmentation

  • In terms of region, the global pericardiocentesis procedures market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global market in 2018 and is likely to gain market share by the end of 2027. The region’s dominance in terms of market share can be attributed to high prevalence and increase in incidence of cancer and cardiovascular diseases in the U.S. and Canada, and well-established healthcare facilities. High per capita healthcare expenditure, favorable medical reimbursement policies, and early adoption of minimally invasive surgeries can be attributed to the region’s large share of the global pericardiocentesis procedures market in 2018.
  • Asia Pacific is projected to be the fastest growing market for pericardiocentesis procedures during the forecast period. Japan dominated the market in the region in 2018. The market in India is anticipated to expand at a high CAGR during the forecast period.
  • The pericardiocentesis procedures market in Latin America and Middle East & Africa is expected to expand at a high CAGR from 2019 to 2027

Pericardiocentesis Procedures Market: Major Players

  • Key players operating in the global pericardiocentesis procedures market are 
    • Cleveland Clinic
    • NewYork-Presbyterian Hospital
    • The Johns Hopkins Hospital
    • Saint George Hospital
    • Buddhist Tzu Chi Medical Foundation
    • J.W. Goethe University Hospital
    • The University of Tokyo Hospital
    • Mediclinic International
    • Apollo Hospitals Enterprise Ltd.
  • These players focus on adopting organic and inorganic growth strategies to expand facility footprint. These companies have adopted strategies such as collaborations & acquisitions, expansion of geographic footprint, and investment in facility infrastructure in order to be competitive in the global pericardiocentesis procedures market.

Pericardiocentesis Procedures Market – Segmentation

Indication

Infections

  • Tuberculosis Infection
  • Bacterial Infection
  • Others

Malignancies

  • Lung Cancer
  • Breast Cancer
  • Lymphoma
  • Others

Inflammatory/Rheumatology

  • Rheumatoid Arthritis
  • Systemic Lupus Erythromatosus
  • Others

Cardiac

Others

End User

Hospitals

Cardiac Centers

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Pericardiocentesis Procedures Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of pericardiocentesis procedures market?

The global pericardiocentesis procedures market was worth US$ 161 Mn and is projected to reach a value of US$ 230 Mn by the end of 2027

What is the anticipated CAGR of the pericardiocentesis procedures market in the forecast period?

Pericardiocentesis procedures market is anticipated to grow at a CAGR of 4% during the forecast period

Which region is expected to project the highest market share in the global pericardiocentesis procedures market?

North America accounted for a major share of the global pericardiocentesis procedures market

What are the key driving factors for the growth of the pericardiocentesis procedures market?

Pericardiocentesis procedures market is expected to be driven by high prevalence and increase in incidence rate of malignancy cancer cases and rapidly increasing geriatric population across the globe

Who are the key players in the global pericardiocentesis procedures market?

Key players in the global pericardiocentesis procedures market include Cleveland Clinic, NewYork-Presbyterian Hospital, The Johns Hopkins Hospital, Saint George Hospital, Buddhist Tzu Chi Medical Foundation, J.W. Goethe University Hospital, The University of Tokyo Hospital, Mediclinic International, and Apollo Hospitals Enterprise Ltd

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pericardiocentesis Procedures Market

4. Market Overview

    4.1. Introduction

        4.1.1. Pericardiocentesis Procedures Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Pericardiocentesis Procedures Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Regulatory Scenario 

    5.2. Overview of Large Pericardial Effusions 

    5.3. Reimbursement Scenario

    5.4. Booming investments in private hospitals in India

6. Global Pericardiocentesis Procedures Market Analysis and Forecast, by Indication 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Indication, 2017–2027

        6.3.1. Infections

            6.3.1.1. Tuberculosis Infection

            6.3.1.2. Bacterial Infection

            6.3.1.3. Others

        6.3.2. Malignancies

            6.3.2.1. Lung Cancer

            6.3.2.2. Breast Cancer

            6.3.2.3. Lymphoma

            6.3.2.4. Others

        6.3.3. Inflammatory/Rheumatology

            6.3.3.1. Rheumatoid Arthritis

            6.3.3.2. Systemic Lupus Erythromatosus

            6.3.3.3. Others

        6.3.4. Cardiac

        6.3.5. Others

    6.4. Market Attractiveness Analysis, by Indication 

7. Global Pericardiocentesis Procedures Market Analysis and Forecast, by End-user

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by End-user, 2017–2027

        7.3.1. Hospitals 

        7.3.2. Cardiac Centers

        7.3.3. Others

    7.4. Market Attractiveness Analysis, by End-user

8. Global Pericardiocentesis Procedures Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. Market Attractiveness Analysis, by Country/Region

9. North America Global Pericardiocentesis Procedures Market Analysis and Forecast

    9.1. Introduction

    9.2. Key Findings

    9.3. Market Value Forecast, by Indication, 2017–2027

        9.3.1. Infections

            9.3.1.1. Tuberculosis Infection

            9.3.1.2. Bacterial Infection

            9.3.1.3. Others

        9.3.2. Malignancies

            9.3.2.1. Lung Cancer

            9.3.2.2. Breast Cancer

            9.3.2.3. Lymphoma

            9.3.2.4. Others

        9.3.3. Inflammatory/Rheumatology

            9.3.3.1. Rheumatoid Arthritis

            9.3.3.2. Systemic Lupus Erythromatosus

            9.3.3.3. Others

        9.3.4. Cardiac

        9.3.5. Others

    9.4. Market Value Forecast, by End-user, 2017–2027

        9.4.1. Hospitals 

        9.4.2. Cardiac Centers

        9.4.3. Others

    9.5. Market Value Forecast, by Country, 2017–2027

        9.5.1. U.S.

        9.5.2. Canada

    9.6. Market Attractiveness Analysis 

        9.6.1. By Indication 

        9.6.2. By End-user

        9.6.3. By Country

10. Europe Global Pericardiocentesis Procedures Market Analysis and Forecast

    10.1. Introduction

    10.2. Key Findings

    10.3. Market Value Forecast, by Indication, 2017–2027

        10.3.1. Infections

            10.3.1.1. Tuberculosis Infection

            10.3.1.2. Bacterial Infection

            10.3.1.3. Others

        10.3.2. Malignancies

            10.3.2.1. Lung Cancer

            10.3.2.2. Breast Cancer

            10.3.2.3. Lymphoma

            10.3.2.4. Others

        10.3.3. Inflammatory/Rheumatology

            10.3.3.1. Rheumatoid Arthritis

            10.3.3.2. Systemic Lupus Erythromatosus

            10.3.3.3. Others

        10.3.4. Cardiac

        10.3.5. Others

    10.4. Market Value Forecast, by End-user, 2017–2027

        10.4.1. Hospitals 

        10.4.2. Cardiac Centers

        10.4.3. Others

    10.5. Market Value Forecast, by Country/Sub-region, 2017–2027

        10.5.1. Germany

        10.5.2. U.K.

        10.5.3. France

        10.5.4. Italy

        10.5.5. Spain

        10.5.6. Rest of Europe

    10.6. Market Attractiveness Analysis 

        10.6.1. By Indication 

        10.6.2. By End-user

        10.6.3. By Country/Sub-region

11. Asia Pacific Global Pericardiocentesis Procedures Market Analysis and Forecast

    11.1. Introduction

    11.2. Key Findings

    11.3. Market Value Forecast, by Indication, 2017–2027

        11.3.1. Infections

            11.3.1.1. Tuberculosis Infection

            11.3.1.2. Bacterial Infection

            11.3.1.3. Others

        11.3.2. Malignancies

            11.3.2.1. Lung Cancer

            11.3.2.2. Breast Cancer

            11.3.2.3. Lymphoma

            11.3.2.4. Others

        11.3.3. Inflammatory/Rheumatology

            11.3.3.1. Rheumatoid Arthritis

            11.3.3.2. Systemic Lupus Erythromatosus

            11.3.3.3. Others

        11.3.4. Cardiac

        11.3.5. Others

    11.4. Market Value Forecast, by End-user, 2017–2027

        11.4.1. Hospitals 

        11.4.2. Cardiac Centers

        11.4.3. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2027

        11.5.1. China

        11.5.2. India

        11.5.3. Japan

        11.5.4. Australia & New Zealand

        11.5.5. Rest of Asia Pacific

    11.6. Market Attractiveness Analysis 

        11.6.1. By Technique 

        11.6.2. By End-user

        11.6.3. By Country/Sub-region

12. Latin America Global Pericardiocentesis Procedures Market Analysis and Forecast

    12.1. Introduction

    12.2. Key Findings

    12.3. Market Value Forecast, by Indication, 2017–2027

        12.3.1. Infections

            12.3.1.1. Tuberculosis Infection

            12.3.1.2. Bacterial Infection

            12.3.1.3. Others

        12.3.2. Malignancies

            12.3.2.1. Lung Cancer

            12.3.2.2. Breast Cancer

            12.3.2.3. Lymphoma

            12.3.2.4. Others

        12.3.3. Inflammatory/Rheumatology

            12.3.3.1. Rheumatoid Arthritis

            12.3.3.2. Systemic Lupus Erythromatosus

            12.3.3.3. Others

        12.3.4. Cardiac

        12.3.5. Others

    12.4. Market Value Forecast, by End-user, 2017–2027

        12.4.1. Hospitals 

        12.4.2. Cardiac Centers

        12.4.3. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2027

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Market Attractiveness Analysis 

        12.6.1. By Technique 

        12.6.2. By End-user

        12.6.3. By Country/Sub-region

13. Middle East and Africa Global Pericardiocentesis Procedures Market Analysis and Forecast

    13.1. Introduction

    13.2. Key Findings

    13.3. Market Value Forecast, by Indication, 2017–2027

        13.3.1. Infections

            13.3.1.1. Tuberculosis Infection

            13.3.1.2. Bacterial Infection

            13.3.1.3. Others

        13.3.2. Malignancies

            13.3.2.1. Lung Cancer

            13.3.2.2. Breast Cancer

            13.3.2.3. Lymphoma

            13.3.2.4. Others

        13.3.3. Inflammatory/Rheumatology

            13.3.3.1. Rheumatoid Arthritis

            13.3.3.2. Systemic Lupus Erythromatosus

            13.3.3.3. Others

        13.3.4. Cardiac

        13.3.5. Others

    13.4. Market Value Forecast, by End-user, 2017–2027

        13.4.1. Hospitals 

        13.4.2. Cardiac Centers

        13.4.3. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2027

        13.5.1. GCC Countries

        13.5.2. South Africa

        13.5.3. Rest of Middle East & Africa

    13.6. Market Attractiveness Analysis 

        13.6.1. By Technique 

        13.6.2. By End-user

        13.6.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (By Tier and Size of companies)

    14.2. Market Share Analysis, by Company, 2018

    14.3. Company Profiles

        14.3.1. New York-Presbyterian Hospital/Weill Cornell Medical Center

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Product Portfolio

            14.3.1.3. SWOT Analysis

            14.3.1.4. Strategic Overview

        14.3.2. Florida Hospital Orlando

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Product Portfolio

            14.3.2.3. SWOT Analysis

            14.3.2.4. Strategic Overview

        14.3.3. Cleveland Clinic

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Product Portfolio

            14.3.3.3. SWOT Analysis

            14.3.3.4. Strategic Overview

        14.3.4. John Hopkins Hospital

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Product Portfolio

            14.3.4.3. SWOT Analysis

            14.3.4.4. Strategic Overview

        14.3.5. Saint George Hospital

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Product Portfolio

            14.3.5.3. SWOT Analysis

            14.3.5.4. Strategic Overview

        14.3.6. Buddhist Tzu Chi General Hospital

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Product Portfolio

            14.3.6.3. SWOT Analysis

            14.3.6.4. Strategic Overview

        14.3.7. J. W. Goethe University Hospital

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Product Portfolio

            14.3.7.3. SWOT Analysis

            14.3.7.4. Strategic Overview

        14.3.8. The University of Tokyo Hospital

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Product Portfolio

            14.3.8.3. SWOT Analysis

            14.3.8.4. Strategic Overview

        14.3.9. Heart Institute, University of Sao Paulo

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Product Portfolio

            14.3.9.3. SWOT Analysis

            14.3.9.4. Strategic Overview

        14.3.10. Mediclinic International

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.10.2. Product Portfolio

            14.3.10.3. SWOT Analysis

            14.3.10.4. Strategic Overview

        14.3.11. Apollo Hospitals Enterprise Ltd

            14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.11.2. Product Portfolio

            14.3.11.3. SWOT Analysis

            14.3.11.4. Strategic Overview

List of Tables

Table 01: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 02: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 03: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 04: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 05: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 06: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 07: Global Pericardiocentesis Procedures Market Volume (Number of Procedures) Forecast, by Region, 2017–2027

Table 08: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country, 2017–2027 

Table 09: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 10: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 11: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 12: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 13: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027 

Table 14: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

Table 15: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 16: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 17: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 18: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 19: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 20: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

Table 21: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 22: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 23: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 24: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 25: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 26: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

Table 27: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 28: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 29: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 30: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 31: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027 

Table 32: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

Table 33: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 34: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 35: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 36: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 37: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027 

List of Figures

Figure 01: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

Figure 02: Global Pericardiocentesis Market Value (US$ Mn) and Volume (Number of Procedures) Forecast, 2017–2027

Figure 03: Global Pericardiocentesis Procedures Market Value Share, by Indication, 2018

Figure 04: Global Pericardiocentesis Procedures Market Value Share, by End-user, 2018

Figure 05: Global Pericardiocentesis Procedures Market Value Share, by Region, 2018

Figure 06: Global Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027

Figure 07: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Y-o-Y Growth, by Infections, 2017–2027

Figure 08: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Y-o-Y Growth, by Malignancies, 2017–2027

Figure 09: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Y-o-Y Growth, by Inflammatory/ Rheumatologic, 2017–2027

Figure 10: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Y-o-Y Growth, by Cardiac, 2017–2027

Figure 11: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027

Figure 12: Global Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027

Figure 13: Global Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027

Figure 14: Global Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027

Figure 15: Global Pericardiocentesis Procedures Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027

Figure 16: Global Pericardiocentesis Procedures Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cardiac Centers, 2017–2027

Figure 17: Global Pericardiocentesis Procedures Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 18: Global Pericardiocentesis Procedures Market Value Share Analysis, by Region, 2018 and 2027 

Figure 19: Global Pericardiocentesis Procedures Market Attractiveness Analysis, by Region, 2019–2027

Figure 20: North America Pericardiocentesis Procedures Market Value (US$ Mn) and Volume (Number of Procedures) Forecast, 2017–2027

Figure 21: North America Pericardiocentesis Procedures Market Value Share Analysis, by Country, 2018 and 2027

Figure 22: North America Pericardiocentesis Procedures Market Attractiveness, by Country, 2019–2027

Figure 23: North America Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027

Figure 24: North America Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027

Figure 25: North America Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027 

Figure 26: North America Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027 

Figure 27: Europe Pericardiocentesis Procedures Market Value (US$ Mn) and Volume (Number of Procedure) Forecast, 2017–2027

Figure 28: Europe Pericardiocentesis Procedures Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 29: Europe Pericardiocentesis Procedures Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 30: Europe Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027

Figure 31: Europe Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027

Figure 32: Europe Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027 

Figure 33: Europe Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027 

Figure 34: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) and Volume (Number of Procedures) Forecast, 2017–2027

Figure 35: Asia Pacific Pericardiocentesis Procedures Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 36: Asia Pacific Pericardiocentesis Procedures Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 37: Asia Pacific Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027

Figure 38: Asia Pacific Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027

Figure 39: Asia Pacific Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027 

Figure 40: Asia Pacific Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027 

Figure 41: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) and Volume (Number of procedures) Forecast, 2017–2027

Figure 42: Latin America Pericardiocentesis Procedures Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 43: Latin America Pericardiocentesis Procedures Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 44: Latin America Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027

Figure 45: Latin America Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027

Figure 46: Latin America Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027 

Figure 47: Latin America Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027 

Figure 48: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) and Volume (Number of procedures) Forecast, 2017–2027

Figure 49: Middle East & Africa Pericardiocentesis Procedures Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 50: Middle East & Africa Pericardiocentesis Procedures Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 51: Middle East & Africa Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027

Figure 52: Middle East & Africa Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027

Figure 53: Middle East & Africa Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027 

Figure 54: Middle East & Africa Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027 

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

259

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved